A detailed history of Rothschild Investment LLC transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, Rothschild Investment LLC holds 210 shares of ALLO stock, worth $648. This represents 0.0% of its overall portfolio holdings.

Number of Shares
210
Previous 22,200 99.05%
Holding current value
$648
Previous $51.7 Million 98.86%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$2.08 - $3.5 $45,739 - $76,965
-21,990 Reduced 99.05%
210 $588,000
Q2 2024

Jul 30, 2024

BUY
$2.23 - $4.38 $49,506 - $97,236
22,200 New
22,200 $51.7 Million
Q4 2023

Jul 31, 2024

SELL
$2.28 - $3.5 $113 - $175
-50 Reduced 0.23%
22,150 $71.1 Million

Others Institutions Holding ALLO

About Allogene Therapeutics, Inc.


  • Ticker ALLO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 143,807,008
  • Market Cap $444M
  • Description
  • Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...
More about ALLO
Track This Portfolio

Track Rothschild Investment LLC Portfolio

Follow Rothschild Investment LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild Investment LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rothschild Investment LLC with notifications on news.